Overview: CesiumJS is a geospatial 3D mapping platform for creating virtual globes. Our mission is to create the leading web-based globe and map for visualizing dynamic data. We strive for the best possible performance, precision, visual quality, ease of use, platform support, and content.
1. Checked the current situation
Australian researchers say they have developed a new tool that could help students cramming for exams – a font that helps the reader remember information.
Melbourne-based RMIT University’s behavioural business lab and design school teamed up to create “Sans Forgetica”, which they say uses psychological and design theories to aid memory retention.
About 400 university students have been involved in a study that found a small increase in the amount participants remembered – 57% of text written in Sans Forgetica compared with 50% in a plain Arial.
Three members of the Expedition 56 crew returned safely to Earth Thursday from the International Space Station, where they spent months providing hands-on support for scientific research in low-Earth orbit, working to keep the orbiting laboratory fully operational, and performing three spacewalks.
NASA astronauts Drew Feustel and Ricky Arnold, and cosmonaut Oleg Artemyev of the Russian space agency Roscosmos landed at 7:44 a.m. EDT (5:44 p.m. in Kazakhstan) southeast of the remote town of Zhezkazgan in Kazakhstan.
The crew completed hundreds of experiments during its 197-day expedition in space. Highlights included an investigation to study ultra-cold quantum gases using the first commercial European facility for microgravity research, and a system that uses surface forces to accomplish liquid-liquid separation…
- A startup called Ambrosia Medical that charges $8,000 to fill your veins with the blood of young people plans to launch its first clinic in New York City at the end of this year.
- Founded by Stanford graduate Jesse Karmazin, the company recently completed the first clinical trialdesigned to assess the benefits of young blood transfusions.
- Although his team has not yet published the results of the trial, Karmazin said the results were “really positive.”
To startup founder and Stanford Medical graduate Jesse Karmazin, blood is the next big government-approved drug.